Welcome to our dedicated page for Definitive Healthcare SEC filings (Ticker: DH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Definitive Healthcare Corp. filings document the regulatory disclosures of a public healthcare data and analytics software company. Recent Form 8-K reports furnish quarterly and annual financial-result releases covering revenue, net loss, adjusted profitability measures, cash flow, guidance, and impairment-related disclosures tied to the company’s subscription-based commercial intelligence platform.
The filing record also includes definitive proxy materials for annual stockholder matters, board elections, executive compensation, equity awards, and governance practices. Other material-event filings document board and committee composition changes, executive-role and compensation arrangements, and the termination of a nominating agreement affecting director-designation rights.
Goldman Sachs Group and Goldman Sachs & Co. LLC report beneficial ownership of 5,935,933 shares of Definitive Healthcare Corp Class A common stock, representing 5.7% of the class as of 12/31/2025.
They report shared voting power over 5,934,807 shares and shared dispositive power over 5,935,933 shares. The firms state the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Definitive Healthcare.
Definitive Healthcare Corp. Executive Chairman Jason Ronald Krantz reported a tax-related share withholding on February 1, 2026. The issuer withheld 44,545 shares of Class A Common Stock at $2.32 per share to cover tax obligations linked to vesting of previously reported restricted stock units.
After this transaction, Krantz beneficially owned 1,016,039 Class A shares directly and 450,000 shares indirectly through DH Holdings (formerly the Jason R. Krantz 2009 Trust), where he is the beneficiary.
Definitive Healthcare Corp. reported a routine insider tax withholding transaction by its Chief Financial Officer. On 02/01/2026, CFO Casey Heller had 1,469 shares of Class A common stock withheld by the company at $2.32 per share to cover tax obligations tied to vesting restricted stock units. After this withholding, Heller beneficially owned 1,274,021 Class A common shares directly.
Definitive Healthcare Corp. reported that its Chief Financial Officer, Casey Heller, received an equity grant of 195,313 Class A common shares in the form of restricted stock units on January 5, 2026. These RSUs carry a grant price of $0 per share, reflecting a compensation award rather than an open-market purchase.
Each RSU represents the right to receive one share of Class A common stock, with 50% vesting on January 1, 2027. The remaining half vests in equal quarterly installments over the following 12 months, conditioned on Heller’s continued service with the company. After this grant, Heller directly beneficially owns 1,275,490 shares of Class A common stock.
Definitive Healthcare Corp. reported Q3 2025 revenue of $60.0 million versus $62.7 million a year ago, with gross profit of $46.0 million. Loss from operations was $8.7 million. Net loss attributable to Definitive Healthcare narrowed to $14.8 million from $130.9 million in Q3 2024, which included a large impairment.
Year to date, revenue was $180.0 million and operating cash flow was $51.1 million. The company reduced its 2021 Term Loan principal to $168.4 million and had no borrowings on its $50.0 million revolver, with $49.7 million available after a standby letter of credit. Total assets were $755.5 million, including goodwill of $216.8 million following a $176.5 million non‑cash goodwill impairment recorded in Q1 2025. Deferred revenue was $92.0 million, and remaining performance obligations totaled $247.3 million. Class A shares outstanding were 103,011,649 as of September 30, 2025.
Definitive Healthcare Corp. (DH) reported a filing action. The company furnished an Item 2.02 Form 8‑K to announce it issued a press release with financial results for the third quarter ended September 30, 2025. The press release is included as Exhibit 99.1. The company states the information in Item 2.02 and Exhibit 99.1 is being furnished, not filed, and is not subject to Section 18 liabilities nor incorporated by reference into other filings.
Definitive Healthcare Corp. (DH) disclosed an insider transaction by its Chief Financial Officer on a Form 4. On 11/01/2025, the CFO had 1,244 shares of Class A common stock withheld at $2.77 per share under transaction code F, which indicates shares were withheld to cover taxes on vested restricted stock units. Following this administrative withholding, the officer beneficially owns 1,080,177 shares directly. The footnote confirms the activity was tied to the vesting and settlement of previously reported RSUs.
Definitive Healthcare (DH) reported an insider transaction by its Executive Chairman and Director. On 11/01/2025, 18,796 shares of Class A common stock were withheld by the company at $2.77 per share to cover tax obligations upon the vesting and settlement of previously reported RSUs. Following this administrative transaction, the reporting person beneficially owns 1,060,584 shares directly and 450,000 shares indirectly through DH Holdings (f/k/a Jason R. Krantz 2009 Trust), of which he is the beneficiary.
Definitive Healthcare Corp. reporting person Casey Heller, the company's Chief Financial Officer, disclosed a transaction on 10/01/2025 in which 8,300 shares of Class A common stock were disposed of at $3.56 per share. After the reported sale, the filing shows the reporting person beneficially owns 1,081,421 shares. The form explains the transaction reflects shares withheld by the issuer to satisfy the reporting person’s tax withholding obligations related to the vesting and settlement of previously reported restricted stock units. The filing is an individual Form 4 and was signed by an attorney-in-fact on behalf of the reporting person.
Kevin Coop, who is listed as both Chief Executive Officer and a Director of Definitive Healthcare Corp. (DH), reported a transaction on 10/01/2025. The report shows a Code F(1) transaction disposing of 37,593 shares of Class A common stock at a price of $3.56 per share. The filing explains these shares were withheld by the issuer to satisfy the reporting person’s tax withholding obligations related to the vesting and settlement of previously reported restricted stock units. After the withholding, the reporting person beneficially owned 3,584,788 shares, held directly. The form is signed by an attorney-in-fact on behalf of the reporting person on 10/03/2025.